Erectile dysfunction and urinary incontinence after prostate cancer treatment
- PMID: 22018407
- DOI: 10.1016/j.soncn.2011.07.006
Erectile dysfunction and urinary incontinence after prostate cancer treatment
Abstract
Objectives: To review the current knowledge and treatment of incontinence and erectile dysfunction after treatment of localized prostate cancer.
Data sources: Journal and research articles.
Conclusion: The unique aspects of each treatment lends to different considerations in treatment techniques that mitigate incontinence and impotence. Although the pathophysiology of incontinence and impotence after various treatments can be different, the treatments can be similar in many ways.
Implications for nursing practice: Nursing care of men undergoing treatment of prostate cancer begins at the time of diagnosis and continues throughout the management of the two main adverse effects of treatment: erectile dysfunction and urinary incontinence. Nursing care focuses heavily on psychosocial support and education to help patients to live with the aftermath of prostate cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.J Natl Cancer Inst. 2004 Sep 15;96(18):1358-67. doi: 10.1093/jnci/djh259. J Natl Cancer Inst. 2004. PMID: 15367568
-
Assessment of patient concern and adequacy of informed consent regarding infertility resulting from prostate cancer treatment.Urology. 2006 Oct;68(4):840-4. doi: 10.1016/j.urology.2006.04.009. Urology. 2006. PMID: 17070364
-
[Erectile dysfunction and incontinence after prostatectomy. Treating the complications of surgery for prostate cancer].Ned Tijdschr Geneeskd. 2012;156(44):A4667. Ned Tijdschr Geneeskd. 2012. PMID: 23114170 Review. Dutch.
-
Reducing adverse effects of treatments for prostate cancer.Prescrire Int. 2012 Oct;21(131):245. Prescrire Int. 2012. PMID: 23185850
-
Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force.Ann Intern Med. 2011 Dec 6;155(11):762-71. doi: 10.7326/0003-4819-155-11-201112060-00375. Epub 2011 Oct 7. Ann Intern Med. 2011. PMID: 21984740 Review.
Cited by
-
The Interplay between Vascular Function and Sexual Health in Prostate Cancer: The Potential Benefits of Exercise Training.Med Sci (Basel). 2020 Feb 11;8(1):11. doi: 10.3390/medsci8010011. Med Sci (Basel). 2020. PMID: 32053955 Free PMC article. Review.
-
Mitochondrial genome variation and prostate cancer: a review of the mutational landscape and application to clinical management.Oncotarget. 2017 Aug 4;8(41):71342-71357. doi: 10.18632/oncotarget.19926. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050365 Free PMC article. Review.
-
Patient-reported genitourinary toxicity for long-term prostate cancer survivors treated with radiation therapy.Br J Cancer. 2013 May 28;108(10):1964-70. doi: 10.1038/bjc.2013.180. Epub 2013 Apr 30. Br J Cancer. 2013. PMID: 23632483 Free PMC article.
-
XGBoost model for predicting erectile dysfunction risk after radical prostatectomy: development and validation using machine learning.Discov Oncol. 2025 May 19;16(1):810. doi: 10.1007/s12672-025-02685-y. Discov Oncol. 2025. PMID: 40387955 Free PMC article.
-
Transrectal Ultrasound in Prostate Cancer: Current Utilization, Integration with mpMRI, HIFU and Other Emerging Applications.Cancer Manag Res. 2022 Mar 22;14:1209-1228. doi: 10.2147/CMAR.S265058. eCollection 2022. Cancer Manag Res. 2022. PMID: 35345605 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
